1. Home
  2. ANGI vs ANTX Comparison

ANGI vs ANTX Comparison

Compare ANGI & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$5.52

Market Cap

198.7M

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.86

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
ANTX
Founded
1995
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.7M
172.9M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
ANGI
ANTX
Price
$5.52
$4.86
Analyst Decision
Buy
Buy
Analyst Count
7
1
Target Price
$17.00
$2.00
AVG Volume (30 Days)
716.3K
189.9K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
32.56
EPS
N/A
N/A
Revenue
$736,386,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.60
N/A
52 Week Low
$4.26
$1.00
52 Week High
$16.97
$7.19

Technical Indicators

Market Signals
Indicator
ANGI
ANTX
Relative Strength Index (RSI) 61.19 33.25
Support Level $4.55 $4.55
Resistance Level $6.52 $5.21
Average True Range (ATR) 0.29 0.36
MACD 0.10 -0.11
Stochastic Oscillator 83.63 5.33

Price Performance

Historical Comparison
ANGI
ANTX

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: